#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy of prematurity Bronchopulmonary aspergillosis Renal cell carcinoma Deafness bilateral Selective polysaccharide antibody deficiency Marginal zone lymphoma refractory Indolent systemic mastocytosis Acquired C1 inhibitor deficiency Pseudomyxoma peritonei Malformation venous Cytokine release syndrome Myocarditis Precursor T-lymphoblastic lymphoma/leukaemia recurrent Brain stem glioma Hairy cell leukaemia recurrent More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Trials in Disease Soft tissue sarcoma – Basic Information Erdheim-Chester disease – Basic Information Chondrosarcoma – Trials in Disease Myelodysplastic syndrome with excess blasts – Diagnostics Pleomorphic leiomyosarcoma CADASIL – Trials in Disease Testicular leiomyosarcoma – Treatment Haemolytic uraemic syndrome – Treatment Metachromatic leukodystrophy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Obexelimab Nms-03592088 Concizumab Palbociclib Cefaclor Bimatoprost Pramipexole Mps-103 Highly Refined Fish Oil Ruzasvir RUBIDIUM CHLORIDE Epirubicin Hydrochloride Ambrosia Artemisiifolia (302) Lenzumestrocel Pilocarpine Nitrate Esk-001 Fasudil Hydrochloride Lisocabtagene Maraleucel Ziftomenib Fexofenadine More therapies…

    Learn about Your Condition

    Connective tissue disorder Metastases to biliary tract Diabetic foot infection Osteochondrodysplasia Small cell carcinoma Albright's disease Cholangiocarcinoma Weaning failure Underweight Arthritis infective Head and neck cancer stage III Malignant melanoma stage III Lichen planus Nicotine dependence Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • HUMANISED IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST THYMIC STROMAL LYMPHOPOIETIN
    Czechia Germany Poland

  • Study of intraperitoneal fosfomycin, metronidazole and molgramostim treatment in patients with multi-quadrant peritonitis during abdominal surgery

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Fosfomycin
    • Molgramostim
    • Metronidazole
    Denmark

  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Img-007
    Czechia Germany Hungary Poland Spain

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DETEMIR
    • Insulin Icodec
    • INSULIN DEGLUDEC
    Germany Italy

  • Study of dronabinol and cannabidiol oral solution for symptom relief in advanced cancer patients receiving opioid treatment

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cancer pain
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Italy

  • Study of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Tucatinib
    • Trastuzumab
    France
Previous Page
1 … 785 786 787 788 789 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!